Journal
Discover Oncology
Discover Oncology is an open access journal publishing content that interfaces at all levels of cancer research.
The scope of investigating the combination of immunotherapy and targeted drug therapies involves a comprehensive approach to advancing cancer treatment by naturally boosting host immunity. This research explores how integrating these two strategies can synergistically enhance therapeutic efficacy, address resistance mechanisms, and offer personalized treatment solutions. Key focus areas include evaluating the synergistic effects of combined therapies, deciphering molecular interactions, and identifying biomarkers for optimal patient selection. Additionally, the scope encompasses assessing safety profiles and clinical outcomes through preclinical models and clinical trials. By addressing these elements, the research aims to refine cancer treatment strategies, improve patient outcomes, and advance personalized medicine.
Keywords:
• Combination Immunotherapy
• Targeted Drug Therapies
• Cancer Treatment
• Host Immunity
• Resistance Mechanisms
• Synergistic Effects
• Molecular Interactions
• Biomarkers
• Preclinical Models
• Clinical Trials
• Personalized Medicine
Submit your manuscript to this collection through the participating journal.
-
Faisal Aziz
PhD, The Hormel Institute-University of Minnesota, USA Dr. Aziz is a Research Scientist specializing in Cancer Biology and Drug Discovery at The Hormel Institute, University of Minnesota. Holding a Ph.D. in Biochemistry and Molecular Biology, he brings extensive expertise in cancer biology, immunology, and infectious diseases. His research focuses on elucidating the molecular mechanisms underlying inflammation and carcinogenesis, with the goal of developing innovative therapeutic strategies through novel drug discoveries. He also contributes to the scientific community as a member of the editorial boards of several journals.
